Dow Dips 150 Points; Bristol Myers Squibb Issues Weak Outlook

1. BMY's Q4 revenue was $12.34 billion, exceeding expectations. 2. Adjusted EPS of $1.67 beat the consensus but fell from last year. 3. For 2025, BMY's EPS forecast is lower than analyst expectations. 4. The company's 2025 sales forecast also misses consensus estimates. 5. Overall market sees mixed results, impacting sector performance.